Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.

Georgakis MK, Malik R, Bounkari OE, Hasbani NR, Li J, Huffman JE, Shakt G, Tack RWP, Kimball TN, Asare Y, Morrison AC, Tsao NL, Judy R, Mitchell BD, Xu H, Montasser ME, Do R, Kenny EE, Loos RJF, Terry JG, Carr JJ, Bis JC, Psaty BM, Longstreth WT, Young KA, Lutz SM, Cho MH, Broome J, Khan AT, Wang FF, Heard-Costa N, Seshadri S, Vasan RS, Palmer ND, Freedman BI, Bowden DW, Yanek LR, Kral BG, Becker LC, Peyser PA, Bielak LF, Ammous F, Carson AP, Hall ME, Raffield LM, Rich SS, Post WS, Tracy RP, Taylor KD, Guo X, Mahaney MC, Curran JE, Blangero J, Clarke SL, Haessler JW, Hu Y, Assimes TL, Kooperberg C, Bernhagen J, Anderson CD, Damrauer SM, Zand R, Rotter JI, de Vries PS, Dichgans M

Open source

DOI
10.1186/s13073-025-01456-2
Published
2025 Mar 21
Container
Genome medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13073-025-01456-2,
  title = {Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.},
  author = {Georgakis MK and Malik R and Bounkari OE and Hasbani NR and Li J and Huffman JE and Shakt G and Tack RWP and Kimball TN and Asare Y and Morrison AC and Tsao NL and Judy R and Mitchell BD and Xu H and Montasser ME and Do R and Kenny EE and Loos RJF and Terry JG and Carr JJ and Bis JC and Psaty BM and Longstreth WT and Young KA and Lutz SM and Cho MH and Broome J and Khan AT and Wang FF and Heard-Costa N and Seshadri S and Vasan RS and Palmer ND and Freedman BI and Bowden DW and Yanek LR and Kral BG and Becker LC and Peyser PA and Bielak LF and Ammous F and Carson AP and Hall ME and Raffield LM and Rich SS and Post WS and Tracy RP and Taylor KD and Guo X and Mahaney MC and Curran JE and Blangero J and Clarke SL and Haessler JW and Hu Y and Assimes TL and Kooperberg C and Bernhagen J and Anderson CD and Damrauer SM and Zand R and Rotter JI and de Vries PS and Dichgans M},
  year = {2025},
  journal = {Genome medicine},
  doi = {10.1186/s13073-025-01456-2},
  url = {https://doi.org/10.1186/s13073-025-01456-2}
}

RIS

TY  - JOUR
TI  - Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.
AU  - Georgakis MK
AU  - Malik R
AU  - Bounkari OE
AU  - Hasbani NR
AU  - Li J
AU  - Huffman JE
AU  - Shakt G
AU  - Tack RWP
AU  - Kimball TN
AU  - Asare Y
AU  - Morrison AC
AU  - Tsao NL
AU  - Judy R
AU  - Mitchell BD
AU  - Xu H
AU  - Montasser ME
AU  - Do R
AU  - Kenny EE
AU  - Loos RJF
AU  - Terry JG
AU  - Carr JJ
AU  - Bis JC
AU  - Psaty BM
AU  - Longstreth WT
AU  - Young KA
AU  - Lutz SM
AU  - Cho MH
AU  - Broome J
AU  - Khan AT
AU  - Wang FF
AU  - Heard-Costa N
AU  - Seshadri S
AU  - Vasan RS
AU  - Palmer ND
AU  - Freedman BI
AU  - Bowden DW
AU  - Yanek LR
AU  - Kral BG
AU  - Becker LC
AU  - Peyser PA
AU  - Bielak LF
AU  - Ammous F
AU  - Carson AP
AU  - Hall ME
AU  - Raffield LM
AU  - Rich SS
AU  - Post WS
AU  - Tracy RP
AU  - Taylor KD
AU  - Guo X
AU  - Mahaney MC
AU  - Curran JE
AU  - Blangero J
AU  - Clarke SL
AU  - Haessler JW
AU  - Hu Y
AU  - Assimes TL
AU  - Kooperberg C
AU  - Bernhagen J
AU  - Anderson CD
AU  - Damrauer SM
AU  - Zand R
AU  - Rotter JI
AU  - de Vries PS
AU  - Dichgans M
PY  - 2025
JO  - Genome medicine
DO  - 10.1186/s13073-025-01456-2
UR  - https://doi.org/10.1186/s13073-025-01456-2
ER  - 

APA

MK, G., R, M., OE, B., NR, H., J, L., JE, H., G, S., RWP, T., TN, K., Y, A., AC, M., NL, T., R, J., BD, M., H, X., ME, M., R, D., EE, K., RJF, L., JG, T., JJ, C., JC, B., BM, P., WT, L., KA, Y., SM, L., MH, C., J, B., AT, K., FF, W., N, H., S, S., RS, V., ND, P., BI, F., DW, B., LR, Y., BG, K., LC, B., PA, P., LF, B., F, A., AP, C., ME, H., LM, R., SS, R., WS, P., RP, T., KD, T., X, G., MC, M., JE, C., J, B., SL, C., JW, H., Y, H., TL, A., C, K., J, B., CD, A., SM, D., R, Z., JI, R., PS, D. V., & M, D. (2025). Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk.. Genome medicine. https://doi.org/10.1186/s13073-025-01456-2

Source records